{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:17:09Z","timestamp":1791191829135,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.taap.2006.09.011","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T14:44:06Z","timestamp":1159800246000},"page":"352-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression"],"prefix":"10.1016","volume":"217","author":[{"given":"Raymond","family":"Hreiche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e9garbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pirnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Borron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Monier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ris\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Descatoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Pessayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric J.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2006.09.011_bib1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM200010263431705","article-title":"Effects of intrathecal morphine on the ventilatory response to hypoxia","volume":"343","author":"Bailey","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2006.09.011_bib2","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/0034-5687(70)90056-3","article-title":"Control of breathing in experimental anemia","volume":"10","author":"Bartlett","year":"1970","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.taap.2006.09.011_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0168-8278(00)00050-7","article-title":"Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation","volume":"34","author":"Berson","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2006.09.011_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1203\/01.PDR.0000117841.81730.2B","article-title":"Ventilatory responses to hypercapnia and hypoxia in conscious cystic fibrosis knockout mice Cftr\u2212\/\u2212","volume":"55","author":"Bonora","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.taap.2006.09.011_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1191\/0960327102ht303oa","article-title":"Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat","volume":"21","author":"Borron","year":"2002","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.taap.2006.09.011_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0034-5687(94)00119-K","article-title":"Alterations in diaphragm activity during opiate-induced respiratory depression","volume":"100","author":"Campbell","year":"1995","journal-title":"Respir. Physiol."},{"key":"10.1016\/j.taap.2006.09.011_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1476-5381.1977.tb07533.x","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2006.09.011_bib8","series-title":"Opioid Overdose: Trends, Risk Factors, Interventions, and Priorities for Action","author":"Donoghoe","year":"1998"},{"key":"10.1016\/j.taap.2006.09.011_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3565(25)10187-0","article-title":"The kappa opioid agonist U-50,488\u00a0H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats","volume":"264","author":"Dosaka-Akita","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib10","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1111\/j.1360-0443.2005.01271.x","article-title":"Harm reduction interventions, behaviors and associated health outcomes in France, 1996\u20132003","volume":"100","author":"Emmanuelli","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.taap.2006.09.011_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1476-5381.1986.tb11121.x","article-title":"The effects of alfentanil and selected narcotic analgesics on the rate of action potential discharge of medullary respiratory neurones in anaesthetized rats","volume":"89","author":"Fone","year":"1986","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2006.09.011_bib12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2006.09.011_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1520\/JFS14667J","article-title":"Fatal intoxication following self-administration of a massive dose of buprenorphine","volume":"45","author":"Gaulier","year":"2000","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0928-0987(02)00009-X","article-title":"Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine","volume":"15","author":"Gopal","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/toxsci\/62.1.148","article-title":"Lack of effect of single high doses of buprenorphine on arterial blood gases in the rat","volume":"62","author":"Gueye","year":"2001","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/65.1.107","article-title":"Buprenorphine and midazolam act in combination to depress respiration in rats","volume":"65","author":"Gueye","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)22291-1","article-title":"Effects of levorphanol and several kappa-selective opioids in respiration and behavior in rhesus monkeys","volume":"245","author":"Howell","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib19","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0024-3205(00)00436-7","article-title":"Effect of buprenorphine on CYP3A activity in rat and human liver microsomes","volume":"66","author":"Ibrahim","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib20","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0024-3205(97)00160-4","article-title":"Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes","volume":"60","author":"Iribarne","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2006.09.011_bib21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2006.09.011_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","article-title":"Deaths involving buprenorphine: a compendium of French cases","volume":"121","author":"Kintz","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.taap.2006.09.011_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0009-9120(02)00304-1","article-title":"A new series of 13 buprenorphine-related deaths","volume":"35","author":"Kintz","year":"2002","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.taap.2006.09.011_bib24","first-page":"818","article-title":"Human buprenorphine N-dealkylation is catalyzed by cytochrome P450 3A4","volume":"26","author":"Kobayashi","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2006.09.011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(95)03155-9","article-title":"Substrates of human hepatic cytochrome P450 3A4","volume":"104","author":"Li","year":"1995","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2006.09.011_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3565(25)20062-3","article-title":"Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms","volume":"232","author":"Ling","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/abbi.1996.9752","article-title":"Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver","volume":"337","author":"Mahnke","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2006.09.011_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2005.04.003","article-title":"Cerebral and plasma kinetics of a high dose of midazolam and correlations with its respiratory effects in rats","volume":"159","author":"M\u00e9garbane","year":"2005","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2006.09.011_bib29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2005.08.002","article-title":"Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation","volume":"212","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2006.09.011_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(84)90594-6","article-title":"Different effects of mu and delta opiate agonists on respiration","volume":"98","author":"Morin-Surun","year":"1984","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2006.09.011_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3565(25)24425-1","article-title":"Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling","volume":"272","author":"Ohtani","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0022-3565(24)36604-2","article-title":"Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine","volume":"281","author":"Ohtani","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199302000-00001","article-title":"Pharmacological mechanisms of opioid analgesics","volume":"16","author":"Pasternak","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.taap.2006.09.011_bib34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/00498258509045363","article-title":"Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant","volume":"15","author":"Pontani","year":"1985","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2006.09.011_bib35","series-title":"The Pharmacological Basis of Therapeutics","first-page":"521","article-title":"Opioid analgesics and antagonists","author":"Reisine","year":"1996"},{"key":"10.1016\/j.taap.2006.09.011_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1176\/ajp.155.3.447-b","article-title":"Six deaths linked to misuse of buprenorphine\u2013benzodiazepine combinations","volume":"155","author":"Reynaud","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.taap.2006.09.011_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/(SICI)1098-2396(199911)34:2<83::AID-SYN1>3.0.CO;2-S","article-title":"Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu\/kappa antagonist in the [35S]GTP-gamma-S-functional binding assay","volume":"34","author":"Romero","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.taap.2006.09.011_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-3565(25)33306-9","article-title":"Buprenorphine: differential interaction with opiate receptor subtypes in vivo","volume":"223","author":"Sadee","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1164\/ajrccm\/142.4.895","article-title":"Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression","volume":"142","author":"Shook","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.taap.2006.09.011_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.annemergmed.2003.11.006","article-title":"Buprenorphine: a primer for emergency physicians","volume":"43","author":"Sporer","year":"2004","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.taap.2006.09.011_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0006-8993(97)01105-0","article-title":"Actions of opioids on respiratory activity via activation of brainstem mu-, delta- and kappa-receptors; an in vitro study","volume":"778","author":"Takita","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2006.09.011_bib42","series-title":"Manual of Pharmacologic Calculations with Computer Programs","author":"Tallarida","year":"1984"},{"key":"10.1016\/j.taap.2006.09.011_bib43","first-page":"440","article-title":"Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications","volume":"178","author":"Toll","year":"1998","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.taap.2006.09.011_bib44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jat\/22.6.430","article-title":"Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities","volume":"22","author":"Tracqui","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.taap.2006.09.011_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/004982500237730","article-title":"Metabolite-intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem","volume":"30","author":"Trieu","year":"2000","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2006.09.011_bib46","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3565(25)25010-8","article-title":"Respiratory effects of morphine in awake unrestrained rats","volume":"237","author":"van den Hoogen","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib48","series-title":"Buprenorphine: Combating Drug Abuse with a Unique Opioid","first-page":"113","article-title":"Absorption, distribution, metabolism and excretion of buprenorphine in animals and humans","author":"Walter","year":"1995"},{"key":"10.1016\/j.taap.2006.09.011_bib49","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1360-0443.1999.9479612.x","article-title":"Mechanisms of fatal opioid overdose","volume":"94","author":"White","year":"1999","journal-title":"Addiction"},{"key":"10.1016\/j.taap.2006.09.011_bib50","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/dmd.31.6.768","article-title":"Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes P450 in vitro","volume":"31","author":"Zhang","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2006.09.011_bib51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(24)36877-6","article-title":"Activation of the cloned human \u03ba opioid receptor by agonists enhances (35S)GTP\u03b3 S binding to membranes: determination of potencies and efficacies of ligands","volume":"282","author":"Zhu","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2006.09.011_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1582-4934.2002.tb00186.x","article-title":"Cytochromes P450 and experimental models of drug metabolism","volume":"6","author":"Zuber","year":"2002","journal-title":"J. Cell. Mol. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X06003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X06003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:38:15Z","timestamp":1758573495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X06003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0041008X06003413"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2006.09.011","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexamethasone hepatic induction in rats subsequently treated with high dose buprenorphine does not lead to respiratory depression","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2006.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}